Shares of Fresenius Medical Care Corporation (NYSE:FMS) have received an average recommendation of “Hold” from the thirteen brokerages that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, five have given a hold rating and seven have given a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $46.00.

FMS has been the topic of a number of recent research reports. Zacks Investment Research upgraded Fresenius Medical Care Corporation from a “hold” rating to a “buy” rating and set a $49.00 target price on the stock in a report on Tuesday, April 25th. Nord/LB restated a “buy” rating on shares of Fresenius Medical Care Corporation in a report on Wednesday, June 28th. BidaskClub lowered Fresenius Medical Care Corporation from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. DZ Bank AG restated a “buy” rating on shares of Fresenius Medical Care Corporation in a report on Monday, August 7th. Finally, Royal Bank Of Canada restated a “hold” rating and issued a $44.00 target price on shares of Fresenius Medical Care Corporation in a report on Wednesday, July 5th.

Several hedge funds have recently modified their holdings of FMS. Harding Loevner LP increased its stake in shares of Fresenius Medical Care Corporation by 6.2% in the second quarter. Harding Loevner LP now owns 3,748,173 shares of the company’s stock worth $181,149,000 after buying an additional 219,213 shares during the last quarter. Cambiar Investors LLC increased its stake in shares of Fresenius Medical Care Corporation by 8.1% in the first quarter. Cambiar Investors LLC now owns 2,516,416 shares of the company’s stock worth $106,017,000 after buying an additional 188,019 shares during the last quarter. Karp Capital Management Corp acquired a new stake in shares of Fresenius Medical Care Corporation during the first quarter worth approximately $7,887,000. Renaissance Technologies LLC acquired a new stake in shares of Fresenius Medical Care Corporation during the first quarter worth approximately $7,141,000. Finally, Bank of America Corp DE increased its stake in shares of Fresenius Medical Care Corporation by 12.1% in the first quarter. Bank of America Corp DE now owns 1,493,411 shares of the company’s stock worth $62,917,000 after buying an additional 161,262 shares during the last quarter. 2.81% of the stock is owned by institutional investors.

WARNING: This piece of content was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/08/18/fresenius-medical-care-corporation-fms-receives-consensus-recommendation-of-hold-from-brokerages.html.

Fresenius Medical Care Corporation (NYSE:FMS) traded down 0.19% during trading on Friday, hitting $46.38. The stock had a trading volume of 101,389 shares. Fresenius Medical Care Corporation has a one year low of $38.05 and a one year high of $50.22. The stock has a 50 day moving average of $47.37 and a 200 day moving average of $44.93. The firm has a market capitalization of $28.46 billion, a P/E ratio of 20.25 and a beta of 0.47.

Fresenius Medical Care Corporation (NYSE:FMS) last posted its earnings results on Tuesday, August 1st. The company reported $0.48 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.53 by $0.05. Fresenius Medical Care Corporation had a net margin of 7.06% and a return on equity of 11.57%. The company had revenue of $4.47 billion during the quarter, compared to the consensus estimate of $5.20 billion. During the same quarter in the prior year, the business earned $0.96 EPS. The firm’s revenue for the quarter was up 11.1% compared to the same quarter last year. Equities research analysts expect that Fresenius Medical Care Corporation will post $2.33 earnings per share for the current fiscal year.

About Fresenius Medical Care Corporation

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Analyst Recommendations for Fresenius Medical Care Corporation (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.